NCT03703089 Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology Status UNKNOWN Phase PHASE1
NCT03703063 Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer Status UNKNOWN Phase PHASE1
NCT03700476 Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma Status UNKNOWN Phase PHASE3
NCT03697564 Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT03697239 High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT03693807 A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT03693677 First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI Status COMPLETED Phase PHASE2
NCT03690739 Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer Status TERMINATED Phase PHASE3
NCT03674242 Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2) Status TERMINATED Phase PHASE2/PHASE3
NCT03673137 Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC Status COMPLETED Phase PHASE2/PHASE3
NCT03673072 Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC Status COMPLETED Phase PHASE3
NCT03668418 Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos Status UNKNOWN Phase N/A
NCT03662074 Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03661320 A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03656536 A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma Status TERMINATED Phase PHASE3
NCT03652428 Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC) Status RECRUITING Phase PHASE1/PHASE2
NCT03649321 Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03636308 Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE2